MolPort-001-794-630

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

67 API Suppliers, 21 USDMF, 20 CEP/COS, 12 JDMF, 3 EU WC, 14 KDMF, 19 NDC API, 35 Listed Suppliers

DEVELOPMENTS

5 Drug(s) in Development

5 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports

INTERMEDIATES

2 Suppliers

2 Suppliers

DOSSIERs // Finished Dosage Formulations

173 Dossiers, 32 FDA Orange Book, 84 Europe, 12 Canada, 5 Australia, 2 South Africa, 38 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - 300MG, TABLET;ORAL - 250MG, TABLET;ORAL - 500MG

CAPSULE;ORAL - 300MG
TABLET;ORAL - 250MG
TABLET;ORAL - 500MG

RELATED EXCIPIENT COMPANIES

Suppliers, 29 Kerry, 29 BASF, 26 Roquette, 12 Microlex e.U, 11 Corel Pharma Chem, 10 Sigachi Industries, 9 Gangwal Healthcare, 8 Gangwal Chemicals, 8 Seppic, 7 Nanjing Well Pharmaceutical, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 Lonza Capsugel, 6 SPI Pharma, 5 DFE Pharma, 5 Ideal Cures Pvt Ltd, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 Actylis, 4 ACG Worldwide, 4 Kima Chemical, 4 Boai NKY Pharmaceuticals Ltd, 3 Ingredion Pharma Solutions, 3 Vasa Pharmachem, 3 Pharmatrans-Sanaq, 3 The Dow Chemical Company, 3 Rochem International Inc, 3 Prachin Chemical, 2 Seqens, 2 Finar, 2 Clariant, 2 Nomisma Healthcare, 2 Qualicaps, 2 DKSH, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Alcedo Pharmachem, 1 Vertellus, 1 Ulanqab Kema New Material, 1 Huzhou Sunflower Pharmaceutical, 1 Nanjing Bold Chemical, 1 Zhejiang Huakang Pharmaceutical, 1 Pharm-RX Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd

EXCIPIENTS BY APPLICATIONS

68 Fillers, Diluents & Binders, 52 Coating Systems & Additives, 32 Controlled & Modified Release, 31 Direct Compression, 25 Thickeners and Stabilizers, 25 Granulation, 24 Film Formers & Plasticizers, 21 Disintegrants & Superdisintegrants, 19 Solubilizers, 18 Taste Masking, 18 Topical, 15 Lubricants & Glidants, 13 Co-Processed Excipients, 12 Parenteral, 9 Chewable & Orodispersible Aids, 9 Empty Capsules, 5 API Stability Enhancers, 4 Rheology Modifiers, 4 Vegetarian Capsules, 3 Emulsifying Agents, 2 Coloring Agents, 2 Surfactant & Foaming Agents, 1 Soft Gelatin

GLOBAL SALES INFORMATION

32 US Medicaid Prescriptions, 76 Finished Drug Prices

MARKET PLACE

24 APIs, 12 DOSSIERS // FDF

PATENTS

2 Health Canada Patents

2 Health Canada Patents

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods, 4 EDQM Standards, 1 USP Standards, 6 Other Ref. Standards

DIGITAL CONTENT

1 Data Compilations & Company Tracker #PharmaFlow, 39 News

List of Suppliers

Full Screen View

Reset Filter

Price Info

ICE Pharma

ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

Contact Supplier

Italy

Virtual Booth

Digital Content

Cholic acid

PDF Supplier PDF

URL Supplier Web Content

CAS Number

6282-60-6

End Use API

Ursodeoxycholic Acid

About The Company

ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most import...

ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and intermediates. ICE Pharma also provides contract manufacturing services for liquid and solid finished dosage forms for branded and generic products. Since October 2019, ICE Pharma has been owned by Advent International, one of the largest and most experienced global private equity investors.